Prof. Dr. med. Ludwig Kappos

Kappos, L., Burcklen, M., D’Ambrosio, D., Fox, R. J., Freedman, M. S., Havrdova, E. K., Hennessy, B., Hohlfeld, R., Larbalestier, A., Lemle, A., Lindenstrøm, E., Lublin, F., Montalban, X., Sidorenko, T., Sprenger, T., Vaclavkova, A., Wuerfel, J., & Pozzilli, C. (2025). Ponesimod as add-on treatment in patients with active relapsing multiple sclerosis under dimethyl fumarate (POINT): A phase 3, randomized, placebo-controlled clinical trial [Journal-article]. Multiple Sclerosis and Related Disorders, 102, 106616. https://doi.org/10.1016/j.msard.2025.106616

Cohen, J. A., Arnold, D. L., DeLuca, J., Hartung, H.-P., Kappos, L., Comi, G., Selmaj, K., Steinman, L., Bar-Or, A., Montalban, X., Havrdová, E. K., Sheffield, J. K., Pachai, C., Cheng, C.-Y., Riolo, J. V., & Cree, B. A. (2025). Brain atrophy and associations with long-term disability and cognitive function in participants with relapsing multiple sclerosis treated with ozanimod: Results from phase 3 and open-label extension trials [Journal-article]. Multiple Sclerosis Journal, 31. https://doi.org/10.1177/13524585251355842

Riccardo, Galbusera, Matthias, Weigel, Erik, Bahn, Sabine, Schaedelin, Alessandro, Cagol, Po-Jui, Lu, Muhamed, Barakovic, Lester, Melie-Garcia, Jonas, Franz, Peter, Dechent, Govind, Nair, Ludwig, Kappos, Wolfgang, Brück, Christine, Stadelmann, & Cristina, Granziera. (2025). Quantitative T1 is sensitive to cortical remyelination in multiple sclerosis: A postmortem MRI study. Brain Pathology, 35, e70010. https://doi.org/10.1111/bpa.70010

Burguet Villena, Federico, Cerdá-Fuertes, Nuria, Hofer, Lisa, Schädelin, Sabine, Sellathurai, Shaumiya, Schoenholzer, Kean, D’Souza, Marcus, Oechtering, Johanna, Hanssen, Henner, Gugleta, Konstantin, Cagol, Alessandro, Granziera, Cristina, Kappos, Ludwig, Petzold, Axel, Benkert, Paskal, Kuhle, Jens, & Papadopoulou, Athina. (2025). Retinal neuronal loss and progression independent of relapse activity in multiple sclerosis. Journal of Neurology, 272(7). https://doi.org/10.1007/s00415-025-13185-y

Montobbio, Noemi, Bovis, Francesca, Signori, Alessio, Carmisciano, Luca, Schiavetti, Irene, Ponzano, Marta, Tur, Carmen, Granziera, Cristina, Cagol, Alessandro, Arnold, Douglas L., Kappos, Ludwig, & Sormani, Maria Pia. (2025). Uncovering a bias in estimated treatment effects on PIRA in multiple sclerosis clinical trials. Ebiomedicine, 117. https://doi.org/10.1016/j.ebiom.2025.105802

Özgür, Yaldizli, Pascal, Benkert, Lutz, Achtnichts, Amit, Bar-Or, Viviane, Bohner-Lang, Claire, Bridel, Manuel, Comabella, Oliver, Findling, Giulio, Disanto, Sebastian, Finkener, Claudio, Gobbi, Cristina, Granziera, Marina, Herwerth, Robert, Hoepner, Dana, Horakova, Nicole, Kamber, Michael, Khalil, Philipp, Kunz, Patrice, Lalive, et al. (2025). Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi Study. Multiple Sclerosis Journal, 31. https://doi.org/10.1177/13524585251335466

Müller, Jannis, Sharmin, Sifat, Lorscheider, Johannes, Ozakbas, Serkan, Karabudak, Rana, Horakova, Dana, Weinstock-Guttman, Bianca, Shaygannejad, Vahid, Etemadifar, Masoud, Alroughani, Raed, Patti, Francesco, Eichau, Sara, Prat, Alexandre, Lugaresi, Alessandra, Tomassini, Valentina, Kermode, Allan G., Amato, Maria Pia, Turkoglu, Recai, Altintas, Ayse, et al. (2025). Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis. JAMA Neurology, 82(6), 614–625. https://doi.org/10.1001/jamaneurol.2025.0495

Bovis, Francesca, Kappos, Ludwig, Arnould, Sophie, Karlsson, Goeril, & Sormani, Maria Pia. (2025). Personalized Treatment Response in Progressive MS: Can the Patient’s Profile Influence the Outcome? Brain and Behavior, 15(6). https://doi.org/10.1002/brb3.70459

Douglas L, Arnold, Shannon, Kolind, Haz-Edine, Assemlal, Amit, Bar-Or, Matilde, Inglese, Ludwig, Kappos, Katrin, Parmar, Till, Sprenger, Anthony, Traboulsee, Irene M, Vavasour, Jerry S, Wolinsky, Corrado, Bernasconi, Ulrike, Bonati, Stefano, Magon, Björn, Tackenberg, & Laura, Gaetano. (2025). Short- and long-term effects of early versus delayed treatment with ocrelizumab on cerebellar volume loss in patients with RMS and PPMS. Multiple Sclerosis Journal, 31(7), 821–832. https://doi.org/10.1177/13524585251325086

Harris, Sarah, Comi, Giancarlo, Cree, Bruce A. C., Arnold, Douglas L., Steinman, Lawrence, Sheffield, James K., Maddux, Rachel, Southworth, Harry, Kappos, Ludwig, & Cohen, Jeffrey A. (2025). Glial Fibrillary Acidic Protein as a Marker of Disease in Relapsing Multiple Sclerosis: Post Hoc Analysis of Phase 3 Ozanimod Trials. European Journal of Neurology, 32(6). https://doi.org/10.1111/ene.70222

Kappos, Ludwig, Yiu, Sean, Dahlke, Frank, Coetzee, Timothy, Cutter, Gary R., Yuen, Steven, Bonati, Ulrike, & Lublin, Fred D. (2025). Composite Confirmed Disability Worsening/Progression Is a Useful Clinical Endpoint for Multiple Sclerosis Clinical Trials. Neurology, 104(10). https://doi.org/10.1212/wnl.0000000000213558

Damiano, Marastoni, Elisa, Colato, Matteo, Foschi, Agnese, Tamanti, Stefano, Ziccardi, Chiara, Eccher, Francesco, Crescenzo, Albulena, Bajrami, Gian Marco, Schiavi, Valentina, Camera, Daniela Anni, Federica, Virla, Maddalena, Guandalini, Ermanna, Turano, Francesca Benedetta, Pizzini, Stefania, Montemezzi, Bruno, Bonetti, Owain, Howell, Roberta, Magliozzi, et al. (2025). Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple Sclerosis. Neurology: Neuroimmunology and NeuroInflammation, 12(4), e200399. https://doi.org/10.1212/nxi.0000000000200399

Géraldine, Androdias, Jan D, Lünemann, Elisabeth, Maillart, Maria Pia, Amato, Bertrand, Audoin, Arlette L, Bruijstens, Gabriel, Bsteh, Helmut, Butzkueven, Olga, Ciccarelli, Alvaro, Cobo-Calvo, Tobias, Derfuss, Franziska, Di Pauli, Gilles, Edan, Christian, Enzinger, Ruth, Geraldes, Cristina, Granziera, Yael, Hacohen, Hans-Peter, Hartung, Sinéad, Hynes, et al. (2025). De-escalating and discontinuing disease-modifying therapies in multiple sclerosis. Brain, 148(5), 1459–1478. https://doi.org/10.1093/brain/awae409

Martina, Greselin, Po-Jui, Lu, Magdalena, Mroczek, Nuria, Cerdá-Fuertes, Anastasios, Demirtzoglou, Athina, Papadopoulou, Jens, Kuhle, David, Leppert, Sophie, Arnould, Manar, Aoun, Ludwig, Kappos, Cristina, Granziera, & Marcus, D’Souza. (2025). AI-assisted identification of disability patterns within identical EDSS grades. Multiple Sclerosis Journal, 31(6), 677–688. https://doi.org/10.1177/13524585251327300

Ocampo-Pineda, Mario, Cagol, Alessandro, Benkert, Pascal, Barakovic, Muhamed, Lu, Po-Jui, Müller, Jannis, Schaedelin, Sabine Anna, Melie-Garcia, Lester, Weigel, Matthias, Sormani, Maria Pia, Kappos, Ludwig, Kuhle, Jens, & Granziera, Cristina. (2025). White Matter Tract Degeneration in Multiple Sclerosis Patients With Progression Independent of Relapse Activity [Journal-article]. Neurology: Neuroimmunology and NeuroInflammation, 12(3). https://doi.org/10.1212/NXI.0000000000200388

Mallucci, Giulia, Zimmer, Andrea, Sfikas, Nikolaos, Cerdá-Fuertes, Nuria, Wunderlin, Simon, Athanasopoulou, Ioanna, Mroczek, Magdalena, Phavanh, Vanny, Sanak, Lisa, Suter, Jolanda, Friedli, Bernadette, Kel, Jakob, Trouillet, Thomas, Simmen, Sarah, Ocampo, Alex, Wei, Wenjia, Kieseier, Bernd, Kamm, Christian P, Kappos, Ludwig, & D’Souza, Marcus. (2025). Neurostatus-SMARTCARE clinical trial: Enabling health care professionals to assess EDSS for decentralized trials in multiple sclerosis. Multiple Sclerosis Journal, 31(4), 497–501. https://doi.org/10.1177/13524585241305966

Müller, Jannis, Sharmin, Sifat, Lorscheider, Johannes, Horakova, Dana, Kubala Havrdova, Eva, Eichau, Sara, Patti, Francesco, Grammond, Pierre, Buzzard, Katherine, Skibina, Olga, Prat, Alexandre, Girard, Marc, Grand’Maison, Francois, Alroughani, Raed, Lechner-Scott, Jeannette, Spitaleri, Daniele, Barnett, Michael, Cartechini, Elisabetta, Sa, Maria Jose, et al. (2025). Treatment De-escalation in Relapsing-Remitting Multiple Sclerosis: An Observational Study. CNS Drugs, 39(4), 403–416. https://doi.org/10.1007/s40263-025-01164-w

Paolo A, Muraro, Alice, Mariottini, Raffaella, Greco, Joachim, Burman, Ellen, Iacobaeus, Matilde, Inglese, John A, Snowden, Tobias, Alexander, Maria Pia, Amato, Lars, Bø, Giacomo, Boffa, Olga, Ciccarelli, Jeffrey A, Cohen, Tobias, Derfuss, Dominique, Farge, Mark S, Freedman, Maria, Gaughan, Christoph, Heesen, Majid, Kazmi, et al. (2025). Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder — recommendations from ECTRIMS and the EBMT. Nature Reviews. Neurology, 21(3), 140–158. https://doi.org/10.1038/s41582-024-01050-x

Ralph, Hb Benedict, Ludwig, Kappos, Aaron, Miller, Hans-Peter, Hartung, James, Overell, Jinglan, Pei, Frank, Dahlke, Corrado, Bernasconi, Harold, Koendgen, Qing, Wang, Ulrike, Bonati, & Stanley, Cohan. (2025). Cognitive effects of ocrelizumab vs interferon β-1a in relapsing multiple sclerosis: A post hoc analysis of the OPERA I/II trials. Multiple Sclerosis and Related Disorders, 95. https://doi.org/10.1016/j.msard.2025.106310

Patrick, Vermersch, Ralf, Gold, Amit, Bar-Or, Bruce A C, Cree, Robert J, Fox, Gavin, Giovannoni, Friedemann, Paul, Sebastian, Wolf, Bingbing, Li, Marie-Catherine, Mousseau, Tina, Maio-Twofoot, Xiaofang, Shi, & Ludwig, Kappos. (2025). Effect of siponimod on retinal thickness, a marker of neurodegeneration, in participants with SPMS: Findings from the EXPAND OCT substudy. Multiple Sclerosis and Related Disorders, 94, 106259. https://doi.org/10.1016/j.msard.2025.106259

Pless, Silvan, Woelfle, Tim, Lorscheider, Johannes, Wiencierz, Andrea, Reyes, Óscar, Luque, Carlos, Calabrese, Pasquale, Granziera, Cristina, & Kappos, Ludwig. (2025). CoGames: Development of an adaptive smartphone-based and gamified monitoring tool for cognitive function in Multiple Sclerosis. Journal of Neurology, 272(2). https://doi.org/10.1007/s00415-024-12818-y

Silvan, Pless, Tim, Woelfle, Johannes, Lorscheider, Andrea, Wiencierz, Óscar, Reyes, Carlos, Luque, Pasquale, Calabrese, Cristina, Granziera, & Ludwig, Kappos. (2025). CoGames: Development of an adaptive smartphone-based and gamified monitoring tool for cognitive function in Multiple Sclerosis. Journal of Neurology, 272(2), 119. https://doi.org/10.1007/s00415-024-12818-y

Oechtering, Johanna, Schaedelin, Sabine Anna, Stein, Kerstin, Maleska Maceski, Aleksandra, Melie-Garcia, Lester, Benkert, Pascal, Cagol, Alessandro, Leber, Selina, Galbusera, Riccardo, Ruberte, Esther, Hu, Wayne, Qureshi, Ferhan, Orleth, Annette, Demuth, Lilian, Willemse, Eline, Heijnen, Ingmar, Regeniter, Axel, Derfuss, Tobias J., Fischer-Barnicol, Bettina, et al. (2025). Aberrant Complement Activation Is Associated With Structural Brain Damage in Multiple Sclerosis [Journal-article]. Neurology: Neuroimmunology and NeuroInflammation, 12(2). https://doi.org/10.1212/nxi.0000000000200361

Benkert, Pascal, Maleska Maceski, Aleksandra, Schaedelin, Sabine, Oechtering, Johanna, Zadic, Amar, Vilchez Gomez, Juan Francisco, Melie-Garcia, Lester, Cagol, Alessandro, Galbusera, Riccardo, Subramaniam, Suvitha, Lorscheider, Johannes, Galli, Edoardo, Mueller, Jannis, Fischer-Barnicol, Bettina, Achtnichts, Lutz, Findling, Oliver, Lalive, Patrice H., Bridel, Claire, Uginet, Marjolaine, et al. (2025). Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B-Cell Depleting Treatment in Multiple Sclerosis. Annals of Neurology, 97, 104–115. https://doi.org/10.1002/ana.27096

Disanto, Giulio, Schaedelin, Sabine, Oechtering, Johanna, Lorscheider, Johannes, Galbusera, Riccardo, Finkener, Sebastian, Achtnichts, Lutz, Lalive, Patrice, Müller, Stefanie, Pot, Caroline, Hoepner, Robert, Salmen, Anke, Zecca, Chiara, Hemkens, Lars G, D’Souza, Marcus, Fischer-Barnicol, Bettina, Du Pasquier, Renaud, Roth, Patrick, Yaldizli, Özgür, et al. (2025). Treatment persistence and clinical outcomes in patients starting B cell depleting therapies within the Swiss MS Cohort. Multiple Sclerosis Journal - Experimental, Translational and Clinical, 11(1). https://doi.org/10.1177/20552173251315457

Pontillo, G., Prados, F., Wink, A. M., Kanber, B., Bisecco, A., Broeders, T. A. A., Brunetti, A., Cagol, A., Calabrese, M., Castellaro, M., Cocozza, S., Colato, E., Collorone, S., Cortese, R., De Stefano, N., Douw, L., Enzinger, C., Filippi, M., Foster, M. A., et al. (2025). More Than the Sum of Its Parts: Disrupted Core Periphery of Multiplex Brain Networks in Multiple Sclerosis. Human Brain Mapping, 46(1). https://doi.org/10.1002/hbm.70107

Sanabria-Diaz, Gretel, Cagol, Alessandro, Lu, Po-Jui, Barakovic, Muhamed, Ocampo-Pineda, Mario, Chen, Xinjie, Weigel, Matthias, Ruberte, Esther, Siebenborn, Nina de Oliveira S., Galbusera, Riccardo, Schädelin, Sabine, Benkert, Pascal, Kuhle, Jens, Kappos, Ludwig, Melie-Garcia, Lester, & Granziera, Cristina. (2025). Advanced MRI Measures of Myelin and Axon Volume Identify Repair in Multiple Sclerosis. Annals of Neurology, 97(1), 134–148. https://doi.org/10.1002/ana.27102

Gomes, Ana Beatriz Ayroza Galvão Ribeiro, Kim, Su-Hyun, Pretzsch, Roxanne, Kulsvehagen, Laila, Schaedelin, Sabine, Lerner, Jasmine, Wetzel, Nora Sandrine, Benkert, Pascal, Maceski, Aleksandra Maleska, Hyun, Jae-Won, Lecourt, Anne-Catherine, Lipps, Patrick, Schoeps, Vinicius Andreoli, De Moura Brasil Matos, Aline, Mendes, Natalia Trombini, Apóstolos-Pereira, Samira Luisa, Mehling, Matthias, Derfuss, Tobias, Kappos, Ludwig, et al. (2024). Neurofilament Light Chain as a Discriminator of Disease Activity Status in MOG Antibody-Associated Disease [Journal-article]. Neurology: Neuroimmunology and NeuroInflammation, 12(1). https://doi.org/10.1212/nxi.0000000000200347

Barakovic, Muhamed, Weigel, Matthias, Cagol, Alessandro, Schaedelin, Sabine, Galbusera, Riccardo, Lu, Po-Jui, Chen, Xinjie, Melie-Garcia, Lester, Ocampo-Pineda, Mario, Bahn, Erik, Stadelmann, Christine, Palombo, Marco, Kappos, Ludwig, Kuhle, Jens, Magon, Stefano, & Granziera, Cristina. (2024). A novel imaging marker of cortical “cellularity” in multiple sclerosis patients [Journal-article]. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-60497-6

Janiaud, Perrine, Zecca, Chiara, Salmen, Anke, Benkert, Pascal, Schädelin, Sabine, Orleth, Annette, Demuth, Lilian, Maceski, Aleksandra Maleska, Granziera, Cristina, Oechtering, Johanna, Leppert, David, Derfuss, Tobias, Achtnichts, Lutz, Findling, Oliver, Roth, Patrick, Lalive, Patrice, Uginet, Marjolaine, Müller, Stefanie, Pot, Caroline, et al. (2024). MultiSCRIPT-Cycle 1—a pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in multiple sclerosis: a study protocol for a randomized clinical trial. Trials, 25(1). https://doi.org/10.1186/s13063-024-08454-6

Oh, J., Capezzuto, L., Kriara, L., Schjodt-Eriksen, J., van Beek, J., Bernasconi, C., Montalban, X., Butzkueven, H., Kappos, L., Giovannoni, G., Bove, R., Julian, L., Baker, M., Gossens, C., & Lindemann, M. (2024). Use of smartphone-based remote assessments of multiple sclerosis in Floodlight Open, a global, prospective, open-access study. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-023-49299-4

Pontillo, Giuseppe, Prados, Ferran, Colman, Jordan, Kanber, Baris, Abdel-Mannan, Omar, Al-Araji, Sarmad, Bellenberg, Barbara, Bianchi, Alessia, Bisecco, Alvino, Brownlee, Wallace J., Brunetti, Arturo, Cagol, Alessandro, Calabrese, Massimiliano, Castellaro, Marco, Christensen, Ronja, Cocozza, Sirio, Colato, Elisa, Collorone, Sara, Cortese, Rosa, et al. (2024). Disentangling Neurodegeneration From Aging in Multiple Sclerosis Using Deep Learning: The Brain-Predicted Disease Duration Gap. Neurology, 103(10). https://doi.org/10.1212/WNL.0000000000209976

Woelfle, Tim, Hirt, Julian, Janiaud, Perrine, Kappos, Ludwig, Ioannidis, John P.A., & Hemkens, Lars G. (2024). Benchmarking Human–AI collaboration for common evidence appraisal tools. Journal of Clinical Epidemiology, 175. https://doi.org/10.1016/j.jclinepi.2024.111533

Geraldes, R., Arrambide, G., Banwell, B., Rovira, À., Cortese, R., Lassmann, H., Messina, S., Rocca, M. A., Waters, P., Chard, D., Gasperini, C., Hacohen, Y., Mariano, R., Paul, F., DeLuca, G. C., Enzinger, C., Kappos, L., Leite, M. I., Sastre-Garriga, J., et al. (2024). The influence of MOGAD on diagnosis of multiple sclerosis using MRI. Nature Reviews Neurology, 20(10), 620–635. https://doi.org/10.1038/s41582-024-01005-2

Cagol, Alessandro, Ocampo-Pineda, Mario, Lu, Po-Jui, Weigel, Matthias, Barakovic, Muhamed, Melie-Garcia, Lester, Chen, Xinjie, Lutti, Antoine, Calabrese, Pasquale, Kuhle, Jens, Kappos, Ludwig, Sormani, Maria Pia, & Granziera, Cristina. (2024). Advanced Quantitative MRI Unveils Microstructural Thalamic Changes Reflecting Disease Progression in Multiple Sclerosis [Journal-article]. Neurology: Neuroimmunology and NeuroInflammation, 11(6). https://doi.org/10.1212/NXI.0000000000200299

Müller, Jannis, Lu, Po-Jui, Cagol, Alessandro, Ruberte, Esther, Shin, Hyeong-Geol, Ocampo-Pineda, Mario, Chen, Xinjie, Tsagkas, Charidimos, Barakovic, Muhamed, Galbusera, Riccardo, Weigel, Matthias, Schaedelin, Sabine A., Wang, Yi, Nguyen, Thanh D., Spincemaille, Pascal, Kappos, Ludwig, Kuhle, Jens, Lee, Jongho, & Granziera, Cristina. (2024). Quantifying Remyelination Using χ-Separation in White Matter and Cortical Multiple Sclerosis Lesions [Journal-article]. Neurology, 103(6). https://doi.org/10.1212/WNL.0000000000209604

Cortese, Rosa, Battaglini, Marco, Prados, Ferran, Gentile, Giordano, Luchetti, Ludovico, Bianchi, Alessia, Haider, Lukas, Jacob, Anu, Palace, Jacqueline, Messina, Silvia, Paul, Friedemann, Marignier, Romain, Durand-Dubief, Françoise, de Medeiros Rimkus, Carolina, Apostolos Pereira, Samira Luisa, Sato, Douglas Kazutoshi, Filippi, Massimo, Rocca, M.A., Cacciaguerra, Laura, et al. (2024). Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis. Annals of Neurology, 96(2), 276–288. https://doi.org/10.1002/ana.26951

Greselin, Martina, Lu, Po-Jui, Melie-Garcia, Lester, Ocampo-Pineda, Mario, Galbusera, Riccardo, Cagol, Alessandro, Weigel, Matthias, de Oliveira Siebenborn, Nina, Ruberte, Esther, Benkert, Pascal, Müller, Stefanie, Finkener, Sebastian, Vehoff, Jochen, Disanto, Giulio, Findling, Oliver, Chan, Andrew, Salmen, Anke, Pot, Caroline, Bridel, Claire, et al. (2024). Contrast-Enhancing Lesion Segmentation in Multiple Sclerosis: A Deep Learning Approach Validated in a Multicentric Cohort [Journal-article]. Bioengineering, 11(8), 858. https://doi.org/10.3390/bioengineering11080858

Sastre-Garriga, J., Vidal-Jordana, A., Toosy, A. T., Enzinger, C., Granziera, C., Frederiksen, J., Ciccarelli, O., Filippi, M., Montalban, X., Tintore, M., Pareto, D., Rovira, À., Rocca, M. A., De Stefano, N., Gasperini, C., Kappos, L., Palace, J., Vrenken, H., Barkhofghi, F., & Yousry, T. A. (2024). Value of Optic Nerve MRI in Multiple Sclerosis Clinical Management: A MAGNIMS Position Paper and Future Perspectives. Neurology, 103(3). https://doi.org/10.1212/wnl.0000000000209677

Kappos, L., Edan, G., Freedman, M. S., Hartung, H.-P., Montalbán, X., Barkhof, F., Koelbach, R., MacManus, D. G., & Wicklein, E.-M. (2024). Long-term clinical outcomes in patients with CIS treated with interferon beta-1b: results from the 15-year follow up of the BENEFIT trial. Journal of Neurology, 271(7), 4599–4609. https://doi.org/10.1007/s00415-024-12417-x

Ciccarelli, O., Barkhof, F., Calabrese, M., De Stefano, N., Eshaghi, A., Filippi, M., Gasperini, C., Granziera, C., Kappos, L., Rocca, M. A., Rovira, À., Sastre-Garriga, J., Sormani, M. P., Tur, C., & Toosy, A. T. (2024). Using the Progression Independent of Relapse Activity Framework to Unveil the Pathobiological Foundations of Multiple Sclerosis [Journal-article]. Neurology, 103(1). https://doi.org/10.1212/wnl.0000000000209444

Chitnis, T., Banwell, B., Kappos, L., Arnold, D. L., Gücüyener, K., Deiva, K., Saubadu, S., Hu, W., Benamor, M., Le-Halpere, A., Truffinet, P., & Tardieu, M. (2024). Teriflunomide in pediatric patients with relapsing multiple sclerosis: Open-label extension of TERIKIDS. Multiple Sclerosis Journal, 30(7), 833–842. https://doi.org/10.1177/13524585241242050

Hirt, Julian, Dembowska, Kinga, Woelfle, Tim, Axfors, Cathrine, Granziera, Cristina, Kuhle, Jens, Kappos, Ludwig, Hemkens, Lars G., & Janiaud, Perrine. (2024). Clinical trial evidence of quality-of-life effects of disease-modifying therapies for multiple sclerosis: a systematic analysis. Journal of Neurology, 271(6), 3131–3141. https://doi.org/10.1007/s00415-024-12366-5

Wendebourg, Maria Janina, Weigel, Matthias, Weidensteiner, Claudia, Sander, Laura, Kesenheimer, Eva, Naumann, Nicole, Haas, Tanja, Madoerin, Philipp, Braun, Nathalie, Neuwirth, Christoph, Weber, Markus, Jahn, Kathleen, Kappos, Ludwig, Granziera, Cristina, Schweikert, Kathi, Sinnreich, Michael, Bieri, Oliver, & Schlaeger, Regina. (2024). Cervical and thoracic spinal cord gray matter atrophy is associated with disability in patients with amyotrophic lateral sclerosis [Journal-article]. European Journal of Neurology, 31(6). https://doi.org/10.1111/ene.16268

Khalil, Michael, Teunissen, Charlotte E., Lehmann, Sylvain, Otto, Markus, Piehl, Fredrik, Ziemssen, Tjalf, Bittner, Stefan, Sormani, Maria Pia, Gattringer, Thomas, Abu-Rumeileh, Samir, Thebault, Simon, Abdelhak, Ahmed, Green, Ari, Benkert, Pascal, Kappos, Ludwig, Comabella, Manuel, Tumani, Hayrettin, Freedman, Mark S., Petzold, Axel, et al. (2024). Neurofilaments as biomarkers in neurological disorders — towards clinical application. Nature Reviews Neurology, 20(5), 269–287. https://doi.org/10.1038/s41582-024-00955-x

Papadopoulou, Athina, Pfister, Armanda, Tsagkas, Charidimos, Gaetano, Laura, Sellathurai, Shaumiya, D’Souza, Marcus, Cerdá-Fuertes, Nuria, Gugleta, Konstantin, Descoteaux, Maxime, Chakravarty, Mallar M., Fuhr, Peter, Kappos, Ludwig, Granziera, Cristina, Magon, Stefano, Sprenger, Till, & Hardmeier, Martin. (2024). Visual evoked potentials in multiple sclerosis: P100 latency and visual pathway damage including the lateral geniculate nucleus [Journal-article]. Clinical Neurophysiology, 161, 122–132. https://doi.org/10.1016/j.clinph.2024.02.020

Fox, R. J., Cree, B. A. C., de Sèze, J., Gold, R., Hartung, H.-P., Jeffery, D., Kappos, L., Montalban, X., Weinstock-Guttman, B., Singh, C. M., Altincatal, A., Belviso, N., Avila, R. L., Ho, P.-R., Su, R., Engle, R., Sangurdekar, D., de Moor, C., Fisher, E., et al. (2024). Temporal Relationship between Serum Neurofilament Light Chain and Radiologic Disease Activity in Patients with Multiple Sclerosis. Neurology, 102(9). https://doi.org/10.1212/wnl.0000000000209357

Woelfle, Tim, Hirt, Julian, Janiaud, Perrine, Kappos, Ludwig, Ioannidis, John P. A., & Hemkens, Lars G. (2024). Benchmarking Human-AI Collaboration for Common Evidence Appraisal Tools [Posted-content]. In medRxiv. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2024.04.21.24306137

Weigel, M., Dechent, P., Galbusera, R., Bahn, E., Lu, P.-J., Kappos, L., Brück, W., Stadelmann, C., & Granziera, C. (2024). Cerebellar Ex Vivo Magnetic Resonance Imaging at its Feasibility Limit: Up to 77-Microns Isotropic Resolution using Low-Bandwidth Balanced Steady State Free Precession (LoBa-bSSFP) Sequences and 3T Standard Equipment [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2024.04.18.589707

Hirt, Julian, Janiaud, Perrine, Düblin, Pascal, Nicoletti, Giovanni Jacopo, Dembowska, Kinga, Nguyen, Thao Vy Thi, Woelfle, Tim, Axfors, Cathrine, Yaldizli, Özgür, Granziera, Cristina, Kuhle, Jens, Kappos, Ludwig, & Hemkens, Lars G. (2024). Use of pragmatic randomized trials in multiple sclerosis: A systematic overview. Multiple Sclerosis Journal, 30(4-5), 463–478. https://doi.org/10.1177/13524585231221938

Lazzarotto, A., Hamzaoui, M., Tonietto, M., Dubessy, A.-L., Khalil, M., Pirpamer, L., Ropele, S., Enzinger, C., Battaglini, M., Stromillo, M. L., De Stefano, N., Filippi, M., Rocca, M. A., Gallo, P., Gasperini, C., Stankoff, B., Bodini, B., Barkhof, F., Sastre-Garriga, J., et al. (2024). Time is myelin: early cortical myelin repair prevents atrophy and clinical progression in multiple sclerosis. Brain, 147(4), 1331–1343. https://doi.org/10.1093/brain/awae024

Janiaud, Perrine, Zecca, Chiara, Salmen, Anke, Benkert, Pascal, Schädelin, Sabine, Orleth, Annette, Demuth, Lilian, Maceski, Aleksandra Maleska, Granziera, Cristina, Oechtering, Johanna, Leppert, David, Derfuss, Tobias, Achtnichts, Lutz, Findling, Oliver, Roth, Patrick, Lalive, Patrice, Uginet, Marjolaine, Müller, Stefanie, Pot, Caroline, et al. (2024). MultiSCRIPT-Cycle 1- A Pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in Multiple Sclerosis: a study protocol for a randomized clinical trial [Posted-content]. In medRxiv. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2024.03.22.24304720

Callegari, Ilaria, Oechtering, Johanna, Schneider, Mika, Perriot, Sylvain, Mathias, Amandine, Voortman, Margarete M., Cagol, Alessandro, Lanner, Ulrike, Diebold, Martin, Holdermann, Sebastian, Kreiner, Victor, Becher, Burkhard, Granziera, Cristina, Junker, Andreas, Pasquier, Renaud Du, Khalil, Michael, Kuhle, Jens, Kappos, Ludwig, Sanderson, Nicholas S.R., & Derfuss, Tobias. (2024). Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5. Brain, 147(3), 839–848. https://doi.org/10.1093/brain/awad424

Gloor M, Andelova M, Gaetano L, Papadopoulou A, Burguet Villena F, Sprenger T, Radue EW, Kappos L, Bieri O, & Garcia M. (2024). Longitudinal analysis of new multiple sclerosis lesions with magnetization transfer and diffusion tensor imaging. European Radiology, 34(3), 1680–1691. https://doi.org/10.1007/s00330-023-10173-6

Oechtering, Johanna, Stein, Kerstin, Schaedelin, Sabine A., Maceski, Aleksandra M., Orleth, Annette, Meier, Stephanie, Willemse, Eline, Qureshi, Ferhan, Heijnen, Ingmar, Regeniter, Axel, Derfuss, Tobias, Benkert, Pascal, D’Souza, Marcus, Limberg, Marguerite, Fischer-Barnicol, Bettina, Achtnichts, Lutz, Mueller, Stefanie, Salmen, Anke, Lalive, Patrice H., et al. (2024). Complement Activation Is Associated With Disease Severity in Multiple Sclerosis [Journal-article]. Neurology: Neuroimmunology and NeuroInflammation, 11(2). https://doi.org/10.1212/NXI.0000000000200212

Cagol, Alessandro, Cortese, Rosa, Barakovic, Muhamed, Schaedelin, Sabine, Ruberte, Esther, Absinta, Martina, Barkhof, Frederik, Calabrese, Massimiliano, Castellaro, Marco, Ciccarelli, Olga, Cocozza, Sirio, De Stefano, Nicola, Enzinger, Christian, Filippi, Massimo, Jurynczyk, Maciej, Maggi, Pietro, Mahmoudi, Nima, Messina, Silvia, Montalban, Xavier, et al. (2024). Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple Sclerosis. JAMA Neurology, 81(2), 143–153. https://doi.org/10.1001/jamaneurol.2023.4737

Kappos, Ludwig, Traboulsee, Anthony, Li, David K. B., Bar-Or, Amit, Barkhof, Frederik, Montalban, Xavier, Leppert, David, Baldinotti, Anna, Schneble, Hans-Martin, Koendgen, Harold, Sauter, Annette, Wang, Qing, & Hauser, Stephen L. (2024). Ocrelizumab exposure in relapsing–remitting multiple sclerosis: 10-year analysis of the phase 2 randomized clinical trial and its extension. Journal of Neurology, 271(2), 642–657. https://doi.org/10.1007/s00415-023-11943-4

Cagol, Alessandro, Benkert, Pascal, Melie-Garcia, Lester, Schaedelin, Sabine A., Leber, Selina, Tsagkas, Charidimos, Barakovic, Muhamed, Galbusera, Riccardo, Lu, Po-Jui, Weigel, Matthias, Ruberte, Esther, Radue, Ernst-Wilhelm, Yaldizli, Özgür, Oechtering, Johanna, Lorscheider, Johannes, D’Souza, Marcus, Fischer-Barnicol, Bettina, Muller, Stefanie, Achtnichts, Lutz, et al. (2024). Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS. Neurology, 102(1). https://doi.org/10.1212/wnl.0000000000207768

Wilson, David, Chan, Dandan, Chang, Lei, Mathis, Robert, Verberk, Inge, Montalban, Xavier, Comabella, Manuel, Fissolo, Nicolas, Bielekova, Bibi, Masvekar, Ruturaj, Chitnis, Tanuja, Ziemssen, Tjalf, Akgün, Katja, Blennow, Kaj, Zetterberg, Henrik, Brück, Wolfgang, Giovannoni, Gavin, Gnanapavan, Sharmilee, Bittner, Stefan, et al. (2024). Development and multi-center validation of a fully automated digital immunoassay for neurofilament light chain: toward a clinical blood test for neuronal injury. Clinical Chemistry and Laboratory Medicine, 62(2), 322–331. https://doi.org/10.1515/cclm-2023-0518

Derfuss, T., Bermel, R., Lin, C.-J., Hauser, S. L., Kappos, L., Vollmer, T., Comi, G., Giovannoni, G., Hartung, H.-P., Weber, M. S., Wang, J., Jessop, N., Chognot, C., Craveiro, L., & Bar-Or, A. (2024). Long-term analysis of infections and associated risk factors in patients with multiple sclerosis treated with ocrelizumab: pooled analysis of 13 interventional clinical trials [Journal-article]. Therapeutic Advances in Neurological Disorders, 17. https://doi.org/10.1177/17562864241277736

Steinegger, L., Nierobisch, N., De Vere-Tyndall, A., Schreiner, B., Roth, P., Kappos, L., Kana, V., & Herwerth, M. (2024). Acute leukoencephalopathy associated with daratumumab treatment in POEMS syndrome: a case report. Frontiers in Immunology, 15. https://doi.org/10.3389/fimmu.2024.1451693

Galbusera, Riccardo, Bahn, Erik, Weigel, Matthias, Cagol, Alessandro, Lu, Po-Jui, Schaedelin, Sabine A., Franz, Jonas, Barakovic, Muhamed, Rahmanzadeh, Reza, Dechent, Peter, Nair, Govind, Brück, Wolfgang, Kuhle, Jens, Kappos, Ludwig, Stadelmann, Christine, & Granziera, Cristina. (2023). Characteristics, Prevalence, and Clinical Relevance of Juxtacortical Paramagnetic Rims in Patients With Multiple Sclerosis. Neurology, 102(3), e207966. https://doi.org/10.1212/wnl.0000000000207966

Abdelhak, Ahmed, Benkert, Pascal, Schaedelin, Sabine, Boscardin, W. John, Cordano, Christian, Oechtering, Johanna, Ananth, Kirtana, Granziera, Cristina, Melie-Garcia, Lester, Montes, Shivany Condor, Beaudry-Richard, Alexandra, Achtnichts, Lutz, Oertel, Frederike C., Lalive, Patrice H., Leppert, David, Müller, Stefanie, Henry, Roland G., Pot, Caroline, Matthias, Amandine, et al. (2023). Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis. JAMA Neurology, 80(12), 1317–1325. https://doi.org/10.1001/jamaneurol.2023.3997

Abdelhak, Ahmed, Benkert, Pascal, Schaedelin, Sabine, Boscardin, W. John, Cordano, Christian, Oechtering, Johanna, Ananth, Kirtana, Granziera, Cristina, Melie-Garcia, Lester, Montes, Shivany Condor, Beaudry-Richard, Alexandra, Achtnichts, Lutz, Oertel, Frederike C., Lalive, Patrice H., Leppert, David, Müller, Stefanie, Henry, Roland G., Pot, Caroline, Matthias, Amandine, et al. (2023). Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis [Journal-article]. JAMA Neurology, 80(12), 1317–1325. https://doi.org/10.1001/jamaneurol.2023.3997

Diouf I, Malpas CB, Sharmin S, Roos I, Horakova D, Kubala Havrdova E, Patti F, Shaygannejad V, Ozakbas S, Eichau S, Onofrj M, Lugaresi A, Alroughani R, Prat A, Duquette P, Terzi M, Boz C, Grand’Maison F, Sola P, et al. (2023). Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: Causal inference to emulate a multiarm randomised trial. Journal of Neurology, Neurosurgery and Psychiatry, 94(12), 1004–1011. https://doi.org/10.1136/jnnp-2023-331499

Hauser, S. L., Kappos, L., Montalban, X., Chognot, C., Jessop, N., Kadner, K., Pradhan, A., Incera, E., & Wolinsky, J. (2023). Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients with Relapsing and Primary Progressive Multiple Sclerosis. Multiple Sclerosis and Related Disorders, 80. https://doi.org/10.1016/j.msard.2023.105308

Montalban, X., Vermersch, P., Arnold, D. L., Bar-Or, A., Cree, B. A. C., Cross, A., Havrdova, E. K., Kappos, L., Stuve, O., Wiendl, H., Wolinsky, J., Bolay, C. L., Hyvert, Y., Javor, A., Guehring, H., Tenenbaum, N., & Tomic, D. (2023). Design and Baseline Characteristics of Phase 3, Double-Blind, Randomised Trials Evaluating the Efficacy and Safety of Evobrutinib Versus Teriflunomide in Relapsing Multiple Sclerosis (evolutionRMS 1 and 2) [Elsevier B.V.]. 80. https://doi.org/10.1016/j.msard.2023.105328

Woelfle, Tim, Pless, Silvan, Reyes, Óscar, Wiencierz, Andrea, Kappos, Ludwig, Granziera, Cristina, & Lorscheider, Johannes. (2023). Smartwatch-derived sleep and heart rate measures complement step counts in explaining established metrics of MS severity. Multiple Sclerosis and Related Disorders, 80. https://doi.org/10.1016/j.msard.2023.105104

Müller, Jannis, Cagol, Alessandro, Lorscheider, Johannes, Tsagkas, Charidimos, Benkert, Pascal, Yaldizli, Özgür, Kuhle, Jens, Derfuss, Tobias, Sormani, Maria Pia, Thompson, Alan, Granziera, Cristina, & Kappos, Ludwig. (2023). Harmonizing Definitions for Progression Independent of Relapse Activity inMultiple Sclerosis A Systematic Review. JAMA Neurology, 80(11), 1232–1245. https://doi.org/10.1001/jamaneurol.2023.3331

Cerdá-Fuertes, Nuria, Stoessel, Marc, Mickeliunas, Gintaras, Pless, Silvan, Cagol, Alessandro, Barakovic, Muhamed, Maceski, Aleksandra Maleska, Álvarez González, Cesar, D’ Souza, Marcus, Schaedlin, Sabine, Benkert, Pascal, Calabrese, Pasquale, Gugleta, Konstantin, Derfuss, Tobias, Sprenger, Till, Granziera, Cristina, Naegelin, Yvonne, Kappos, Ludwig, Kappos, Ludwig, et al. (2023). Optical coherence tomography versus other biomarkers: Associations with physical and cognitive disability in multiple sclerosis. Multiple Sclerosis Journal, 29(13), 1540–1550. https://doi.org/10.1177/13524585231198760

Galbusera, Riccardo, Bahn, Erik, Weigel, Matthias, Schaedelin, Sabine, Franz, Jonas, Lu, Po-Jui, Barakovic, Muhamed, Melie-Garcia, Lester, Dechent, Peter, Lutti, Antoine, Sati, Pascal, Reich, Daniel S., Nair, Govind, Brück, Wolfgang, Kappos, Ludwig, Stadelmann, Christine, & Granziera, Cristina. (2023). Postmortem quantitative MRI disentangles histological lesion types in multiple sclerosis. Brain Pathology, 33(6). https://doi.org/10.1111/bpa.13136

Callegari, I., Oechtering, J., Schneider, M., Perriot, S., Mathias, A., Voortman, M. M., Cagol, A., Lanner, U., Diebold, M., Holdermann, S., Kreiner, V., Becher, B., Granziera, C., Junker, A., Du Pasquier, R., Khalil, M., Kuhle, J., Kappos, L., Sanderson, N., & Derfuss, T. (2023). Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5 [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2023.09.29.560121

Hauser S.L., Kappos L., Bar-Or A., Wiendl H., Paling D., Williams M., Gold R., Chan A., Milo R., Das Gupta A., Karlsson G., Sullivan R., Graham G., Merschhemke M., Haring D.A., & Vermersch P. (2023). The Development of Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody for Practical Use in Relapsing Multiple Sclerosis Treatment. Neurology and Therapy, 12(5), 1491–1515. https://doi.org/10.1007/s40120-023-00518-0

Hauser, S. L., Zielman, R., Das Gupta, A., Xi, J., Stoneman, D., Karlsson, G., Robertson, D., Cohen, J. A., & Kappos, L. (2023). Efficacy and safety of four-year ofatumumab treatment in relapsing multiple sclerosis: The ALITHIOS open-label extension. Multiple Sclerosis Journal, 29(11-12), 1452–1464. https://doi.org/10.1177/13524585231195346

Ayroza Galvão Ribeiro Gomes, Ana Beatriz, Kulsvehagen, Laila, Lipps, Patrick, Cagol, Alessandro, Cerdá-Fuertes, Nuria, Neziraj, Tradite, Flammer, Julia, Lerner, Jasmine, Lecourt, Anne-Catherine, De Oliveira S. Siebenborn, Nina, Cortese, Rosa, Schaedelin, Sabine, Andreoli Schoeps, Vinicius, De Moura Brasil Matos, Aline, Trombini Mendes, Natalia, Dos Reis Pereira, Clarissa, Ribeiro Monteiro, Mario Luiz, Dos Apóstolos-Pereira, Samira Luisa, Schindler, Patrick, et al. (2023). Immunoglobulin A Antibodies Against Myelin Oligodendrocyte Glycoprotein in a Subgroup of Patients with Central Nervous System Demyelination. JAMA Neurology, 80(9), 989–995. https://doi.org/10.1001/jamaneurol.2023.2523

Abdelhak, Ahmed, Petermeier, Franziska, Benkert, Pascal, Schädelin, Sabine, Oechtering, Johanna, Maleska Maceski, Aleksandra, Kabesch, Michael, Geis, Tobias, Laub, Otto, Leipold, Georg, Gobbi, Claudio, Zecca, Chiara, Green, Ari, Tumani, Hayrettin, Willemse, Eline, Wiendl, Heinz, Granziera, Cristina, Kappos, Ludwig, Leppert, David, et al. (2023). Serum neurofilament light chain reference database for individual application in paediatric care: a retrospective modelling and validation study. The Lancet Neurology, 22(9), 826–833. https://doi.org/10.1016/s1474-4422(23)00210-7

Harding-Forrester, Sam, Roos, Izanne, Nguyen, Ai-Lan, Malpas, Charles B, Diouf, Ibrahima, Moradi, Nahid, Sharmin, Sifat, Izquierdo, Guillermo, Eichau, Sara, Patti, Francesco, Horakova, Dana, Kubala Havrdova, Eva, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Grand’Maison, Francois, Onofrj, Marco, Lugaresi, Alessandra, Grammond, Pierre, et al. (2023). Disability accrual in primary and secondary progressive multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 94(9), 707–717. https://doi.org/10.1136/jnnp-2022-330726

Todea, Alexandra Ramona, Melie-Garcia, Lester, Barakovic, Muhamed, Cagol, Alessandro, Rahmanzadeh, Reza, Galbusera, Riccardo, Lu, Po-Jui, Weigel, Matthias, Ruberte, Esther, Radue, Ernst-Wilhelm, Schaedelin, Sabine, Benkert, Pascal, Oezguer, Yaldizli, Sinnecker, Tim, Müller, Stefanie, Achtnichts, Lutz, Vehoff, Jochen, Disanto, Giulio, Findling, Oliver, et al. (2023). A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients. Journal of Magnetic Resonance Imaging, 58(3), 864–876. https://doi.org/10.1002/jmri.28618

van Munster, Caspar E.P., Burggraaff, Jessica, Steinheimer, Saskia, Kamm, Christian P., D’Souza, Marcus, Diederich, Manuela, Dorn, Jonas, Walsh, Lorcan, Dahlke, Frank, Kappos, Ludwig, & Uitdehaag, Bernard M.J. (2023). Assessment of Multiple Aspects of Upper Extremity Function Independent From Ambulation in Patients With Multiple Sclerosis. International Journal of MS Care, 25(5), 226–232. https://doi.org/10.7224/1537-2073.2021-069

Bar-Or, Amit, Thanei, Gian-Andrea, Harp, Christopher, Bernasconi, Corrado, Bonati, Ulrike, Cross, Anne H., Fischer, Saloumeh, Gaetano, Laura, Hauser, Stephen L., Hendricks, Robert, Kappos, Ludwig, Kuhle, Jens, Leppert, David, Model, Fabian, Sauter, Annette, Koendgen, Harold, Jia, Xiaoming, & Herman, Ann E. (2023). Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials. eBioMedicine, 93. https://doi.org/10.1016/j.ebiom.2023.104662

Pless S, Woelfle T, Naegelin Y, Lorscheider J, Wiencierz A, Reyes Ó, Calabrese P, & Kappos L. (2023). Assessment of cognitive performance in multiple sclerosis using smartphone-based training games: a feasibility study. Journal of Neurology, 270(7), 3451–3463. https://doi.org/10.1007/s00415-023-11671-9

Neziraj, Tradite, Kappos, Ludwig, & Pröbstel, Anne-Katrin. (2023). Moving toward personalized B cell depletion in multiple sclerosis? Med, 4(6), 344–346. https://doi.org/10.1016/j.medj.2023.05.006

Cortese R., Battaglini M., Prados F., Bianchi A., Haider L., Jacob A., Palace J., Messina S., Paul F., Wuerfel J., Marignier R., Durand-Dubief F., de Medeiros Rimkus C., Callegaro D., Sato D.K., Filippi M., Rocca M.A., Cacciaguerra L., Rovira A., et al. (2023). Clinical and MRI measures to identify non-acute MOG-antibody disease in adults. Brain, 146(6), 2489–2501. https://doi.org/10.1093/brain/awac480

Tsagkas, Charidimos, Huck-Horvath, Antal, Cagol, Alessandro, Haas, Tanja, Barakovic, Muhamed, Amann, Michael, Ruberte, Esther, Melie-Garcia, Lester, Weigel, Matthias, Pezold, Simon, Schlaeger, Regina, Kuhle, Jens, Sprenger, Till, Kappos, Ludwig, Bieri, Oliver, Cattin, Philippe, Granziera, Cristina, & Parmar, Katrin. (2023). Anterior horn atrophy in the cervical spinal cord: A new biomarker in progressive multiple sclerosis. Multiple Sclerosis Journal, 29(6), 702–718. https://doi.org/10.1177/13524585221139152

Pfeuffer S., Rolfes L., Ingwersen J., Pul R., Kleinschnitz K., Korsen M., Rauber S., Ruck T., Schieferdecker S., Willison A.G., Aktas O., Kleinschnitz C., Hartung H.-P., Kappos L., & Meuth S.G. (2023). Effect of Previous Disease-Modifying Therapy on Treatment Effectiveness for Patients Treated With Ocrelizumab. Neurology: Neuroimmunology and NeuroInflammation, 10(3). https://doi.org/10.1212/nxi.0000000000200104

Cagol A, Fuertes NC, Stoessel M, Barakovic M, Schaedelin S, D’Souza M, Würfel J, Brandt AU, Kappos L, Sprenger T, Naegelin Y, Kuhle J, Granziera C, & Papadopoulou A. (2023). Optical coherence tomography reflects clinically relevant gray matter damage in patients with multiple sclerosis. Journal of Neurology, 270(4), 2139–2148. https://doi.org/10.1007/s00415-022-11535-8

Diouf I., Malpas C.B., Sharmin S., Roos I., Horakova D., Havrdova E.K., Patti F., Shaygannejad V., Ozakbas S., Izquierdo G., Eichau S., Onofrj M., Lugaresi A., Alroughani R., Prat A., Girard M., Duquette P., Terzi M., Boz C., et al. (2023). Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis. European Journal of Neurology, 30(4), 1014–1024. https://doi.org/10.1111/ene.15706

Vrenken H., Battaglini M., de Vos M.L., Nagtegaal G.J., Teixeira B.C.A., Seitzinger A., Jack D., Sormani M.P., Uitdehaag B.M.J., Versteeg A., Comi G., Kappos L., De Stefano N., & Barkhof F. (2023). Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1a. Journal of Neurology, 270(4), 2271–2282. https://doi.org/10.1007/s00415-022-11554-5

Hauser S.L., Bar-Or A., Weber M.S., Kletzl H., Gunther A., Manfrini M., Model F., Mercier F., Petry C., Wing Q., Koendgen H., Smith T., & Kappos L. (2023). Association of Higher Ocrelizumab Exposure With Reduced Disability Progression in Multiple Sclerosis. Neurology: Neuroimmunology and NeuroInflammation, 10(2). https://doi.org/10.1212/nxi.0000000000200094

Meier, Stephanie, Willemse, Eline A.J., Schaedelin, Sabine, Oechtering, Johanna, Lorscheider, Johannes, Melie-Garcia, Lester, Cagol, Alessandro, Barakovic, Muhamed, Galbusera, Riccardo, Subramaniam, Suvitha, Barro, Christian, Abdelhak, Ahmed, Thebault, Simon, Achtnichts, Lutz, Lalive, Patrice, Müller, Stefanie, Pot, Caroline, Salmen, Anke, Disanto, Giulio, et al. (2023). Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis. JAMA Neurology, 80(3), 287–297. https://doi.org/10.1001/jamaneurol.2022.5250

Kuhle J, Chitnis T., Banwell B., Tardieu M., Arnold DL, Rawlings A.M., Geertsen S.S., Lublin AL, Saubadu S., Truffinet P., & Kappos L. (2023). Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trial. Multiple Sclerosis Journal, 29(3), 385–394. https://doi.org/10.1177/13524585221144742

Tsagkas, Charidimos, Huck-Horvath, Antal, Cagol, Alessandro, Haas, Tanja, Amann, Michael, Barakovic, Muhamed, Ruberte, Esther, Melie-Garcia, Lester, Weigel, Matthias, Pezold, Simon, Schlaeger, Regina, Kuhle, Jens, Sprenger, Till, Kappos, Ludwig, Bieri, Oliver, Cattin, Philippe, Granziera, Cristina, & Parmar, Katrin. (2023). Longitudinal assessment of cervical spinal cord compartments in multiple sclerosis [Journal-article]. Multiple Sclerosis and Related Disorders, 71, 104545. https://doi.org/10.1016/j.msard.2023.104545

Tsagkas C, Huck-Horvath A, Cagol A, Haas T, Amann M, Barakovic M, Ruberte E, Melie-Garcia L, Weigel M, Pezold S, Schlaeger R, Kuhle J, Sprenger T, Kappos L, Bieri O, Cattin P, Granziera C, & Parmar K. (2023). Longitudinal assessment of cervical spinal cord compartments in multiple sclerosis. Multiple Sclerosis and Related Disorders, 71, 104545. https://doi.org/10.1016/j.msard.2023.104545

Granziera, Cristina, Derfuss, Tobias, & Kappos, Ludwig. (2023). Time to Change the Current Clinical Classification of Multiple Sclerosis? JAMA Neurology, 80(2), 128–130. https://doi.org/10.1001/jamaneurol.2022.4156

Wenger, A.L., Barakovic, Muhamed, Bosticardo, Sara, Schaedelin, Sabine, Daducci, Alessandro, Schiavi, Simona, Weigel, Matthias, Rahmanzadeh, Reza, Lu, Po-Jui, Cagol, Alessandro, Kappos, Ludwig, Kuhle, Jens, Calabrese, Pasquale, & Granziera, Cristina. (2023). An investigation of the association between focal damage and global network properties in cognitively impaired and cognitively preserved patients with multiple sclerosis. Frontiers in Neuroscience, 17. https://doi.org/10.3389/fnins.2023.1007580

Tsagkas, C., Horvath-Huck, A., Haas, T., Amann, M., Todea, A., Altermatt, A., Müller, J., Cagol, A., Leimbacher, M., Barakovic, M., Weigel, M., Pezold, S., Sprenger, T., Kappos, L., Bieri, O., Granziera, C., Cattin, P., & Parmar, K. (2023). Fully Automatic Method for Reliable Spinal Cord Compartment Segmentation in Multiple Sclerosis [Journal-article]. American Journal of Neuroradiology, 44(2), 218–227. https://doi.org/10.3174/ajnr.A7756

Ziemssen T., Bhan V., Chataway J., Chitnis T., Campbell Cree B.A., Havrdova E.K., Kappos L., Labauge P., Miller A., Nakahara J., Oreja-Guevara C., Palace J., Singer B., Trojano M., Patil A., Rauser B., & Hach T. (2023). Secondary Progressive Multiple Sclerosis: A Review of Clinical Characteristics, Definition, Prognostic Tools, and Disease-Modifying Therapies. Neurology: Neuroimmunology and NeuroInflammation, 10(1). https://doi.org/10.1212/nxi.0000000000200064

Bühler A, Wolbers M, Model F, Wang Q, Belachew S, Manfrini M, Lorscheider J, Kappos L, & Beyersmann J. (2023). Recurrent disability progression endpoints in multiple sclerosis clinical trials. Multiple Sclerosis Journal, 29(1), 130–139. https://doi.org/10.1177/13524585221125382

Callegari, Ilaria, Schneider, Mika, Aebischer, Vera, Voortman, Margarete M., Proschmann, Undine, Ziemssen, Tjalf, Lindberg, Raija, Fischer-Barnicol, Bettina, Khalil, Michael, Kappos, Ludwig, Kuhle, Jens, Sanderson, Nicholas S.R., & Derfuss, Tobias. (2023). Natalizumab in cerebrospinal fluid and breastmilk of patients with multiple sclerosis. Therapeutic Advances in Neurological Disorders, 16. https://doi.org/10.1177/17562864221150040

Cerdá-Fuertes, Nuria, Nagy, Sara, Schaedelin, Sabine, Sinnecker, Tim, Ruberte, Esther, Papadopoulou, Athina, Würfel, Jens, Kuhle, Jens, Yaldizli, Özgür, Kappos, Ludwig, Derfuss, Tobias, & Décard, Bernhard F. (2023). Evaluation of frequency, severity, and independent risk factors for recurrence of disease activity after fingolimod discontinuation in a large real-world cohort of patients with multiple sclerosis. Therapeutic Advances in Neurological Disorders, 16. https://doi.org/10.1177/17562864221150312